These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16808058)

  • 1. Increasing molecular mass allows better tumor targeting and retention of cancer therapy.
    Cancer Biol Ther; 2006 Apr; 5(4):339-40. PubMed ID: 16808058
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposome-based drug delivery in breast cancer treatment.
    Park JW
    Breast Cancer Res; 2002; 4(3):95-9. PubMed ID: 12052251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
    Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
    Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted drug delivery for breast cancer treatment.
    Jin S; Ye K
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets.
    Nienhuis HH; Gaykema SB; Timmer-Bosscha H; Jalving M; Brouwers AH; Lub-de Hooge MN; van der Vegt B; Overmoyer B; de Vries EG; Schröder CP
    Pharmacol Ther; 2015 Mar; 147():63-79. PubMed ID: 25444756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as targeted drug delivery systems in the treatment of breast cancer.
    Sharma G; Anabousi S; Ehrhardt C; Ravi Kumar MN
    J Drug Target; 2006 Jun; 14(5):301-10. PubMed ID: 16882550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beating the odds. Finely tuned diagnoses and targeted drugs are creating optimism about surviving breast cancer.
    Hobson K
    US News World Rep; 2005 Jun; 138(22):62-4, 67-8, 70. PubMed ID: 15974027
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanoparticle delivery for metastatic breast cancer.
    Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
    Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
    Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
    Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a systems engineering approach to cancer drug delivery.
    Dreher MR; Chilkoti A
    J Natl Cancer Inst; 2007 Jul; 99(13):983-5. PubMed ID: 17596569
    [No Abstract]   [Full Text] [Related]  

  • 14. San Antonio Breast Cancer Symposium--27th Annual Meeting.
    Susman E
    IDrugs; 2005 Jan; 8(1):21-4. PubMed ID: 15650936
    [No Abstract]   [Full Text] [Related]  

  • 15. What is targeted therapy?
    Sledge GW
    J Clin Oncol; 2005 Mar; 23(8):1614-5. PubMed ID: 15755966
    [No Abstract]   [Full Text] [Related]  

  • 16. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Targeting Nanoparticles for Breast Cancer.
    Alqaraghuli HGJ; Kashanian S; Rafipour R
    Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the delivery of cancer drugs that block angiogenesis.
    Cao Y; Langer R
    Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermo-responsive fibrinogen nanogels: a viable thermo-responsive drug delivery agent for breast cancer therapy?
    Sreerenganathan M; Mony U; Rangasamy J
    Nanomedicine (Lond); 2014 Dec; 9(18):2721-3. PubMed ID: 25535683
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis.
    Li M; Tang Z; Zhang Y; Lv S; Li Q; Chen X
    Acta Biomater; 2015 May; 18():132-43. PubMed ID: 25735801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.